EMCDDA Document Library

The development and distribution of an effective and safe vaccine against the coronavirus represents a lasting solution to the pandemic and a cornerstone of the European Commission's coronavirus response.

There are currently no authorised vaccines for COVID-19 in the European Union (EU). The European Medicines Agency (EMA) is liaising closely with developers of potential COVID-19 vaccines, mobilising its own resources and cooperating with regulatory partners, to ensure safe and effective vaccines...

This document presents the annex to the European Commission's Communication on the EU Agenda and Action Plan on Drugs 2021-25.

This evaluation assesses the degree of implementation of the EU Drugs Strategy 2013– 2020 and the Action Plan 2013–2016 in terms of outputs and, to the extent possible, impacts.